X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (437) 437
Publication (76) 76
Book Chapter (10) 10
Book Review (5) 5
Conference Proceeding (2) 2
Magazine Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bedaquiline (425) 425
index medicus (279) 279
tuberculosis (237) 237
humans (151) 151
pharmacology & pharmacy (118) 118
delamanid (114) 114
microbiology (105) 105
multidrug-resistant tuberculosis (99) 99
infectious diseases (89) 89
antitubercular agents - therapeutic use (87) 87
mycobacterium-tuberculosis (82) 82
respiratory system (76) 76
tuberculosis, multidrug-resistant - drug therapy (76) 76
mycobacterium tuberculosis - drug effects (75) 75
mycobacterium tuberculosis (74) 74
drug resistance (69) 69
antitubercular agents - pharmacology (58) 58
atp synthase (58) 58
clofazimine (56) 56
drug resistance in microorganisms (51) 51
antitubercular agents (50) 50
mdr-tb (50) 50
drugs (49) 49
chemistry, medicinal (44) 44
drug therapy (44) 44
pulmonary tuberculosis (42) 42
multidrug-resistant (41) 41
treatment outcome (41) 41
diarylquinolines - therapeutic use (40) 40
female (39) 39
pharmacokinetics (39) 39
tmc207 (39) 39
early bactericidal activity (38) 38
male (36) 36
microbial sensitivity tests (36) 36
pyrazinamide (36) 36
immunology (35) 35
animals (34) 34
analysis (33) 33
drug-resistant tuberculosis (33) 33
safety (32) 32
adult (31) 31
susceptibility (30) 30
xdr-tb (30) 30
drug (29) 29
moxifloxacin (29) 29
linezolid (27) 27
tolerability (27) 27
tuberculosis - drug therapy (27) 27
antitubercular agents - administration & dosage (25) 25
antitubercular agents - adverse effects (25) 25
care and treatment (25) 25
in-vitro (25) 25
rifampin (25) 25
diarylquinolines - pharmacology (24) 24
murine model (24) 24
nitroimidazoles - therapeutic use (24) 24
resistance (24) 24
therapy (24) 24
tuberculosis, multidrug-resistant - microbiology (24) 24
biochemistry & molecular biology (23) 23
efficacy (23) 23
metaanalysis (23) 23
tuberculosis, pulmonary - drug therapy (23) 23
infectious and parasitic diseases (22) 22
management (22) 22
cross-resistance (21) 21
diarylquinoline tmc207 (21) 21
drug approval (21) 21
drug discovery (21) 21
drug therapy, combination (21) 21
extensively drug-resistant tuberculosis - drug therapy (21) 21
mycobacterium tuberculosis - genetics (21) 21
oxazoles - therapeutic use (21) 21
pa-824 (21) 21
patients (21) 21
review (21) 21
antibiotics (20) 20
diagnosis (20) 20
diarylquinolines (20) 20
diarylquinolines - adverse effects (20) 20
extensively drug-resistant tuberculosis (20) 20
resistant tuberculosis (20) 20
treatment outcomes (20) 20
antitubercular agents - chemistry (19) 19
bacteria (19) 19
medicine (19) 19
middle aged (19) 19
outcomes (19) 19
chemistry, organic (18) 18
clinical trials (17) 17
drug-resistance (17) 17
hiv (17) 17
mutation (17) 17
regimens (17) 17
antitubercular agents - pharmacokinetics (16) 16
multidrug resistance (16) 16
research (16) 16
tuberculosis, multidrug-resistant - epidemiology (16) 16
article (15) 15
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (421) 421
Russian (13) 13
French (5) 5
Korean (4) 4
German (3) 3
Chinese (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The European respiratory journal, ISSN 0903-1936, 10/2018, Volume 52, Issue 4
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 05/2018, Volume 26, Issue 8, pp. 1797 - 1809
Replacing the naphthalene C-unit of the anti-tuberculosis drug bedaquiline with a range of bicyclic heterocycles of widely differing lipophilicity gave analogs... 
Bedaquiline analogs | Tuberculosis | Drug development | Bedaquiline | MYCOBACTERIUM-TUBERCULOSIS | CHEMISTRY, MEDICINAL | DIARYLQUINOLINES | ASSAY | BIOCHEMISTRY & MOLECULAR BIOLOGY | MULTIDRUG-RESISTANT TUBERCULOSIS | CHEMISTRY, ORGANIC | Antitubercular agents | International cooperation | Research institutes | Drug therapy
Journal Article
LANCET INFECTIOUS DISEASES, ISSN 1473-3099, 02/2019, Volume 19, Issue 2, pp. 135 - 136
Journal Article
European Respiratory Journal, ISSN 0903-1936, 09/2016, Volume 48, Issue 3, pp. 938 - 943
The World Health Organization (WHO) estimated that 480000 new multidrug-resistant (MDR) tuberculosis (TB) cases occurred globally in 2014, with 190000 deaths.... 
BEDAQUILINE | DELAMANID | RESPIRATORY SYSTEM | DISEASE
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 07/2018, Volume 115, Issue 28, pp. 7326 - 7331
Bedaquiline (BDQ), an inhibitor of the mycobacterial F1Fo-ATP synthase, has revolutionized the antitubercular drug discovery program by defining energy... 
Tuberculosis | Bedaquiline | General | Ionophore | Uncoupler | Respiration
Journal Article
The Journal of infection, ISSN 0163-4453, 01/2020, Volume 80, Issue 1, pp. 38 - 41
Prioritisation of oral bedaquiline over the injectable agents in the treatment of multidrug-resistant Tuberculosis (MDR-TB) in the World Health Organisations... 
Journal Article
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, ISSN 0066-4804, 10/2019, Volume 63, Issue 10
The antituberculosis drug bedaquiline (BDQ) inhibits Mycobacterium tuberculosis F-ATP synthase by interfering with two subunits. Drug binding to the c subunit... 
SYSTEM | diarylquinoline | MECHANISM | ANALOGS | DRUG BEDAQUILINE | MICROBIOLOGY | ADENOSINE-TRIPHOSPHATASE | c subunit | epsilon subunit | IDENTIFICATION | bedaquiline | TBAJ-876 | DIARYLQUINOLINES | F-ATP synthase | RESISTANCE | PHARMACOLOGY & PHARMACY
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2019, Volume 69, Issue 11, pp. 2038 - 2039
Journal Article
Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, 11/2019, Volume 176, p. 112775
This article describes the simultaneous determination of bedaquiline fumarate (TMC-207) and rifabutin in human plasma by stable isotope dilution tandem mass... 
TMC-207 | Mycobacterium tuberculosis | Stable isotope dilution tandem mass spectrometry | Rifabutuin | Bedaquiline | 25-O-Desacetylrifabutin | Bedaquiline metabolite M2 | CHEMISTRY, ANALYTICAL | DIARYLQUINOLINES | ATP SYNTHASE | PHARMACOLOGY & PHARMACY
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 04/2019, Volume 27, Issue 7, pp. 1283 - 1291
The ATP-synthase inhibitor bedaquiline is effective against drug-resistant tuberculosis but is extremely lipophilic (clogP 7.25) with a very long plasma... 
Tuberculosis | Drug development | Bedaquiline analogues | Lipophilicity | Bedaquiline | CHEMISTRY, MEDICINAL | DIARYLQUINOLINES | ASSAY | BIOCHEMISTRY & MOLECULAR BIOLOGY | MULTIDRUG-RESISTANT TUBERCULOSIS | CHEMISTRY, ORGANIC | TMC207 | Drug resistance in microorganisms | Plasma physics | International cooperation | Pyridine | Pharmacy | Research institutes | Drug therapy
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 02/2018, Volume 61, Issue 3, pp. 791 - 803
Inhibition of the mycolic acid pathway has proven a viable strategy in antitubercular drug discovery. The AccA3/AccD4/FadD32/Pks13 complex of Mycobacterium... 
PKS13 | BEDAQUILINE | DELAMANID | CHEMISTRY, MEDICINAL | CATALYZES | MYCOLIC ACID BIOSYNTHESIS | MEMBRANE | RECEPTOR | DIARYLQUINOLINE
Journal Article
Clinical Pharmacology in Drug Development, ISSN 2160-763X, 05/2019, Volume 8, Issue 4, pp. 436 - 442
There is an urgent need to identify safe and effective combination treatments for multidrug‐resistant (MDR) Mycobacterium tuberculosis infection (TB).... 
pharmacokinetics | bedaquiline metabolites | bedaquiline | rifabutin | rifampin | PHARMACOLOGY & PHARMACY | PHARMACODYNAMICS | RIFAPENTINE | TMC207
Journal Article
Journal Article
ACS Medicinal Chemistry Letters, ISSN 1948-5875, 10/2017, Volume 8, Issue 10, pp. 1019 - 1024
Bedaquiline (1) is a new drug for tuberculosis and the first of the diarylquinoline class. It demonstrates excellent efficacy against TB but induces... 
lipophilicity | ATP synthase | diarylquinoline | hERG | Bedaquiline | tuberculosis | DRUG | CHEMISTRY, MEDICINAL | TMC207
Journal Article
CLINICS IN CHEST MEDICINE, ISSN 0272-5231, 12/2019, Volume 40, Issue 4, pp. 811 - 811
Tuberculosis (TB) has now surpassed HIV as the leading infectious cause of death, and treatment success rates are declining. Multidrug-resistant TB,... 
MYCOBACTERIUM-TUBERCULOSIS | Delamanid | EARLY BACTERICIDAL ACTIVITY | NITROIMIDAZOPYRAN PA-824 | Bedaquiline | Pharmacology | ANTITUBERCULOSIS DRUG | MURINE MODEL | IN-VITRO | Tuberculosis | New drugs | STERILIZING ACTIVITY | RESPIRATORY SYSTEM | POPULATION PHARMACOKINETICS | MULTIDRUG-RESISTANT TUBERCULOSIS | Pretomanid | BEDAQUILINE TMC207
Journal Article
SAMJ SOUTH AFRICAN MEDICAL JOURNAL, ISSN 0256-9574, 01/2020, Volume 110, Issue 1, pp. 32 - 37
Background. Optimal drug levels and minimal toxicity are critical factors in improving treatment outcomes for patients prescribed new and repurposed medicine... 
BEDAQUILINE | MEDICINE, GENERAL & INTERNAL | MULTIDRUG-RESISTANT | PHARMACOKINETICS | REGIMEN | OUTCOMES
Journal Article
EUROPEAN RESPIRATORY JOURNAL, ISSN 0903-1936, 12/2019, Volume 54, Issue 6
The World Health Organization (WHO) recommends that countries implement pharmacovigilance and collect information on active drug safety monitoring (aDSM) and... 
BEDAQUILINE | MULTIDRUG-RESISTANT | EFFICACY | SAFETY | RESPIRATORY SYSTEM | TOLERABILITY | XDR-TB | OUTCOMES | REGIMENS
Journal Article
CLINICAL INFECTIOUS DISEASES, ISSN 1058-4838, 10/2019, Volume 69, Issue 7, pp. 1229 - 1231
Two new drugs, delamanid and bedaquiline, have recently been approved for treatment of multidrug-resistant and extensively drug-resistant (XDR) tuberculosis.... 
INFECTIOUS DISEASES | MICROBIOLOGY | IMMUNOLOGY | bedaquiline resistance | XDR-tuberculosis | delamanid resistance
Journal Article
Tuberculosis, ISSN 1472-9792, 07/2019, Volume 117, pp. 79 - 84
Bedaquiline was approved by USFDA in 2012 for pulmonary MDR-TB. The IC value of bedaquiline was reported to be remarkably low (25 nM), effectively inhibiting... 
Hepatotoxicity | Bedaquiline | Cardiotoxicity | ANALOGS | DRUG BEDAQUILINE | MICROBIOLOGY | IMMUNOLOGY | DISCOVERY | DIARYLQUINOLINES | ATP SYNTHASE | RESPIRATORY SYSTEM | MULTIDRUG-RESISTANT TUBERCULOSIS | TMC207 | Analysis | Tuberculosis | Organic chemistry | ATP synthase | Toxicity | Liver | Chemists | Inhibition | Pharmacokinetics | Potassium | Optimization
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.